Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s ...

Until recently, the popular weight loss treatment called Wegovy was only available in injection form. The newly-launched ...

Autonomous trucking product liability risks are rising as technology outpaces regulations. Explore legal challenges, ...

Peptides are everywhere; they’re unavoidable. Insulin is a peptide. So are GLP-1s—the Ozempics and Mounjaros of the world.

Vermont State Treasurer Mike Pieciak will be in Montpelier on Thursday with other state officials to discuss a new program that is meant to help residents save money on prescription medications.

At-home devices are becoming a standard part of people’s daily skin-care routines. In 2026, a turbulent economy means people ...

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation associated with ...

Vera Therapeutics stock rose on FDA acceptance of atacicept BLA for priority review in IgAN, a potential multi-billion dollar ...

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...